Literature DB >> 7466571

Gastrointestinal carcinoids and the malignant carcinoid syndrome.

H Beaton, W Homan, P Dineen.   

Abstract

The records of 59 patients with gastrointestinal carcinoid tumors at The New York Hospital from 1948 to 1978 were reviewed. Forty-seven instances were diagnosed surgically; 12 were identified on autopsy specimens. The average age at diagnosis was 55.8 years. No association with duodenal ulcer or carcinoma could be made. The appendix was the mose common site of origin, followed by the ileum, rectum and colon, respectively. Jejunoileal carcinoids were multiple in 37 per cent of the patients. Primary tumors of the colon had the highest malignant potential and only two patients had the malignant carcinoid syndrome. Radical excision of all primary tumors is advocated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7466571

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Primary malignant small bowel tumors: an atypical abdominal emergency.

Authors:  K J Mitchell; E S Williams; L D Leffall
Journal:  J Natl Med Assoc       Date:  1995-04       Impact factor: 1.798

2.  Viability of endoscopic and excisional treatment of early rectal carcinoids.

Authors:  Anders Merg; Debrah Wirtzfeld; Jiping Wang; Richard Cheney; Kelli Bullard Dunn; Ashwani Rajput
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

3.  Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis.

Authors:  J M Feldman; R S Jones
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

4.  Carcinoid tumour of ampulla of Vater associated with viscero-cutaneous neurofibromatosis.

Authors:  B M Kapur; S K Sarin; C S Anand; K Varma
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

5.  Gastrointestinal carcinoid tumors: factors that predict outcome.

Authors:  Jamie J Van Gompel; Rebecca S Sippel; Tom F Warner; Herbert Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.